FilmArra Pneumonia Panel plus (Pneumoplus), REF: RFIT-LBL-0374 Recall
FilmArra Pneumonia Panel plus (Pneumoplus), REF: RFIT-LBL-0374
FDA recall Class II
Ongoing
FDA lists this Class II recall for FilmArra Pneumonia Panel plus (Pneumoplus), REF: RFIT-LBL-0374. Review the affected identifiers, reported reason and manufacturer instructions below.
Recall at a glance
- Recall number
- Z-1518-2025
- Recall classification
- Class II
- Enforcement status
- Ongoing
- Initiation date
- Feb 27, 2025
- FDA report date
- Apr 16, 2025
- Quantity in commerce
- 29 kits
- Distribution
- See key details
- FDA cause
- Nonconforming Material/Component
What is being recalled?
FilmArra Pneumonia Panel plus (Pneumoplus), REF: RFIT-LBL-0374
Affected model & UDI checker
Search the exact identifiers published for Z-1518-2025.
The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.
Affected products
| Model / catalog number | Product | Lot scope reported | UDI / GTIN |
|---|---|---|---|
| RFIT-LBL-0374 | FilmArra Pneumonia Panel plus (Pneumoplus), REF: RFIT-LBL-0374 | Check source notice | Not specified |
| Not specified | FilmArra Pneumonia Panel plus (Pneumoplus), REF: RFIT-LBL-0374 | Check source notice | 00815381020314 |
FDA code information
UDI: 00815381020314/Lot# 0979424
Why was this product recalled?
Increased risk of control failures and false negative test results with multiplexed nucleic acid test.
What actions did Biofire Diagnostics, LLC take?
On February 28, 2025, Biomerieux issued an "Urgent Field Safety Notice" Recall notification to affected consignees via email. The notice described the product, problem and actions to be taken. Biomerieux asked consignees to take the following actions: " Immediately examine your inventory for the lot identified in this field safety notice. " Discontinue use and discard any remaining product from this lot in your possession. bioMrieux will replace the product at no charge in accordance with our standard limited warranty. " Confirm the amount of pouches scrapped (if any) on the attached Acknowledgement of Receipt Form. " If you have further distributed this product, please identify any recipients and notify them at once. " Please complete the accompanying Acknowledgement of Receipt Form and return to bioMrieux so that bioMrieux may acknowledge your receipt of this notification. If you require additional assistance or have any questions, please contact your local bioMrieux Customer Service representative or call customer service department at 1-800-736-6354.
Read the manufacturer action recorded by FDARecall timeline
Recall initiated by firm
FDA notice posted
FDA classification recorded
FDA enforcement report date
Related FDA submissions
No submission number with an exact verified relationship is linked in the retrieved recall notice.
FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.
Source and update history
- FDA recall notice Z-1518-2025
- openFDA enforcement record · Source release Nov 11, 2026 · Retrieved Nov 22, 2026
- openFDA device recall record · Source release Nov 19, 2026 · Retrieved Nov 22, 2026
- FDA enforcement data
First stored snapshot of this source.
- FDA device-recall notice
First stored snapshot of this source.
The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.
Our data sources and methodology